Key result
Hypothermic circulatory arrest was non-inferior to left heart bypass for 30-day mortality (OR 1.19; 95% CI 0.31-4.59; P=0.14) during repair of DTA and TAA pathologies.
Why the study?
Most large-volume centres use left heart bypass as their preferred organ protection strategy during repair of DTA and TAA pathologies; this study investigates the use of hypothermic circulatory arrest and compares outcomes of both.
Does hypothermic circulatory arrest provide equivalent organ protection compared to left heart bypass in patients undergoing open repair of descending thoracic aortic and thoracoabdominal aortic pathologies?
Meta-Analysis
Does hypothermic circulatory arrest provide equivalent organ protection compared to left heart bypass in patients undergoing open repair of descending thoracic aortic and thoracoabdominal aortic pathologies?
Odds Ratio: 1.19 (95% CI 0.31–4.59)
p-value: p=0.14
Hypothermic circulatory arrest appears to provide equivalent organ protection to left heart bypass during open repair of descending thoracic and thoracoabdominal aortic pathologies, with no significant differences in mortality or major morbidities.
Background Most large‐volume centres use left heart bypass (LHB) as their preferred organ protection strategy during repair of descending thoracic aortic (DTA) and thoracoabdominal aortic (TAA) pathologies. We investigate the use of hypothermic circulatory arrest (HCA) for similar pathologies and compare the outcomes of both. Methods A PubMed, Embase and Scopus search for studies in English on LHB versus HCA for repair of DTA and TAA pathologies published from inception till February 2020 was performed. Our analysis excluded studies without direct comparison of the two organ protection strategies. Clinical endpoints that were studied were 30‐day mortality, post‐operative stroke, spinal cord deficit, renal failure and respiratory failure. Random effects meta‐analyses of the effect of the two strategies across all clinical endpoints were conducted. Results HCA is non‐inferior to LHB across all clinical endpoints. In terms of 30‐day mortality (odds ratio (OR) 1.19, 95% confidence interval (CI) 0.31–4.59, P = 0.14, I2 = 49%), stroke (OR 0.41, 95% CI 0.12–1.39, P = 0.97, I2 = 0%), spinal cord deficit (OR 0.56, 95% CI 0.22–1.45, P = 0.78, I2 = 0%), renal failure (OR 1.33, 95% CI 0.37–4.76, P = 0.98, I2 = 0%) and respiratory failure (OR 0.86, 95% CI 0.37–1.97, P = 0.16, I2 = 46%), there was no statistically significant difference between the two cohorts. Conclusion Evidence is limited, but suggests that HCA alone provides adequate organ protection during repair of DTA and TAA pathologies, and has equivalent outcomes when compared to LHB.
No takes yet. Share an insight, caveat, or question.
Papadimas et al. (2020) conducted a meta-analysis in Descending thoracic aortic (DTA) and thoracoabdominal aortic (TAA) pathologies. Hypothermic circulatory arrest (HCA) vs. Left heart bypass (LHB) was evaluated on 30-day mortality (OR 1.19, 95% CI 0.31-4.59, p=0.14). Hypothermic circulatory arrest was non-inferior to left heart bypass for 30-day mortality (OR 1.19; 95% CI 0.31-4.59; P=0.14) during repair of DTA and TAA pathologies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: